Association of Interferon-gamma gene polymorphism (+874 T/A) with systemic sclerosis

Disease Markers

Volumn 27, Issue 2, 2009, Pages 93-95

  Wastowski, Isabela J ^a,c   Sampaio Barros, Percival D ^a,b   Martelli Palomino, Gustavo ^a   Marques Neto, Joo Francisco ^b   Crispim, Janaina C O ^a   Rassi, Diane M ^a   Donadi, Eduardo A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c PONTIFÍCIA UNIVERSIDADE CATÓLICA DE GOIÁS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC SCLEROSIS; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETIC POLYMORPHISM; GENETICS; POLYMERASE CHAIN REACTION;

CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; INTERFERON-GAMMA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SCLERODERMA, SYSTEMIC;

EID: 74049142508     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/936152     Document Type: Article

References (12)

1. E.C. LeRoy, A brief overview of the pathogenesis of scleroderma (systemic sclerosis), Ann Rheum Dis 51 (1992), 286-288.
2. C. Mauch, B. Eckes, N. Hunzelmann, T. Oono, E. Kozlowska and T. Krieg, Control of fibrosis in systemic scleroderma, J Invest Dermatol 100 (1993), 92-96.
3. M.R. Duncan and B. Berman, Persistence of a reducedcollagen- producing phenotype in cultured scleroderma fibroblasts after short term exposure to interferons, J Clin Invest 79 (1987), 1318-1324.
4. A.S. Narayanan, J. Whithey, A. Souza and G. Raghu, Effect of g-interferon on collagen synthesis by normal and fibrotic human lung fibroblasts, Chest 101 (1992), 1326-1331.
5. R.P. Polisson, G.S. Gilkeson, E.H. Pyun, D.S. Pisetsky, E.A. Smith and L.S. Simon, A multicenter trial of recombinant human IFN-g in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels, J Rheumatol 23 (1996), 654-658.
6. V. Pravica, A. Asderakis, C. Perrey et al., In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene, Eur J Immunogenet 26(1) (1999), 1-3.
7. V. Pravica, C. Perrey, A. Stevens et al., A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production, Hum Immunol 61(9) (2000), 863-866.
8. A.T. Masi, G.P. Rodan, T.A. Medsger Jr. et al., Preliminary criteria for the classification of systemic sclerosis (scleroderma), Arthritis Rheum 23 (1980), 581-590.
9. E.C. LeRoy, C. Black, R. Fleischmajer et al, Scleroderma (systemic sclerosis): classification, subsets and pathogenesis, J Rheumatol 15 (1988), 202-205.
10. S. Romagnani, TH1 and TH2 in human diseases, Clin Immunol Immunopathol 80 (1996), 225-235.
11. M.I. Molteni, S. Della Bella, B. Mascagni, S. Bazzi, C. Zulian, S. Compasso, M. Lessi and R. Scorza, Increased interferon-gamma (IFN-g) levels produced in vitro by alloactivated T lymphocytes in systemic sclerosis and Raynaud's phenomenon, Clin Exp Immunol 116 (1999), 164-168.
12. M. Tangwattanachuleeporn, P. Sodsai, Y. Avihingsanon, J. Wongpiyabovorn, J.Wongchinsri and N. Hirankarn, Association of interferon-gamma gene polymorphism (+874A) with arthritis manifestation in SLE, Clin Rheumatol 26 (2007), 1921-1924.